Labcorp HoldingsLH +1.85%79 OCF Margin % is 5.41% as of Mar. 2026, which is 57% below its 10-year median of 12.52. GuruFocus rates LH with a GF Score™ of 79/100 and a GF Value™ of $271.41 (Fairly Valued). The stock has 6 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Labcorp Holdings ranks better than 65.2% on this metric.
The historical rank and industry rank for Labcorp Holdings's OCF Margin % or its related term are showing as below:
LH'
s OCF Margin % Range Over the Past 10 Years
Min: 10.92 Med: 12.52 Max: 23.67
Current: 12.82
During the past 13 years, the highest OCF Margin % of Labcorp Holdings was 23.67%. The lowest was 10.92%. And the median was 12.52%.
LH's OCF Margin % is ranked better than 65.2% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: 4.755
vs LH: 12.82
Labcorp Holdings OCF Margin % Related Terms
Labcorp Holdings OCF Margin % Historical Data
* Premium members only.
The historical data trend for Labcorp Holdings's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Labcorp Holdings's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Labcorp Holdings OCF Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Labcorp Holdings's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Labcorp Holdings's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Labcorp Holdings (LH) has a OCF Margin % of 5.41% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Labcorp Holdings and its competitors. This is 57% below median its historical median of 12.52. Over the past decade, Labcorp Holdings' OCF Margin % has ranged from 10.92 to 23.67. According to the industry distribution chart, Labcorp Holdings ranks #71 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 34.8%.
Is Labcorp Holdings' OCF Margin % too high?
Labcorp Holdings' current OCF Margin % of 5.41% is 57% below median its 10-year median of 12.52. Over the past 10 years, this metric has ranged from a low of 10.92 to a high of 23.67. The Medical Diagnostics & Research industry median OCF Margin % is 4.76. Labcorp Holdings' value of 5.41% is 13.8% above this industry median. Based on the distribution chart, Labcorp Holdings ranks #71 out of 204 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Labcorp Holdings has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Labcorp Holdings' OCF Margin % compare to DGX and MTD?
According to the Medical Diagnostics & Research industry distribution chart, Labcorp Holdings ranks #71 out of 204 companies for OCF Margin %. This puts Labcorp Holdings in the upper half of its industry. The industry median OCF Margin % is 4.76. Labcorp Holdings' value of 5.41% is 13.8% above this benchmark. Historically, Labcorp Holdings' own OCF Margin % has ranged from 10.92 to 23.67 over the past decade. While the company's 10-year median is 12.52 vs. the industry median of 4.76, Labcorp Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Diagnostics & Research company?
The median OCF Margin % among Medical Diagnostics & Research companies is 4.76, based on 204 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Labcorp Holdings's current OCF Margin % of 5.41% is 13.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Labcorp Holdings and its competitors. For the Medical Diagnostics & Research industry, the median OCF Margin % is 4.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Labcorp Holdings's current OCF Margin % is 5.41%, which is 57% below median its own 10-year median of 12.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labcorp Holdings stock overvalued right now?
Based on GuruFocus' analysis, Labcorp Holdings (LH) is currently considered Fairly Valued. The stock's GF Value™ is $271.41, compared to a current price of $270.08 — trading 0.5% below its estimated fair value. The current OCF Margin % is 5.41%, which is 57% below median its 10-year median of 12.52 and 13.8% above the Medical Diagnostics & Research industry median of 4.76. Labcorp Holdings' overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Labcorp Holdings (LH), the current OCF Margin % is 5.41% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Labcorp Holdings (LH) Overvalued in 2026?
Based on GuruFocus' analysis, Labcorp Holdings stock appears to be undervalued.
The current stock price of $270.08 is trading 0.5% below its estimated GF Value™ of $271.41.
GuruFocus considers Labcorp Holdings to be Fairly Valued.
Key valuation signals for LH:
OCF Margin %: 5.41% (57% below median its 10-year median of 12.52)
GF Value™: $271.41 vs. price of $270.08 (0.5% below fair value)
Industry Position: 13.8% above the Medical Diagnostics & Research median (#71 of 204)
No single metric tells the full story. See the LH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
79GF Score
Get the complete analysis for LH
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LH has been successfully added to your 
